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Acute immune complex disease  (serum sickness)  in rabbits may be induced by a 
single large, intravenous injection  of an antigen, such as bovine serum albumin (BSA).I 
When the animal mounts an immune response against the antigen and synthesizes 
antibodies, immune complexes between antibody and antigen form and circulate in the 
blood. Deposition of these complexes  in blood vessel walls initiates the characteristic 
glomerulonephritis and vasculitis. The deposition is associated with increased vascular 
permeability (6, 7) and can be prevented by administration  of antagonists of histamine 
and serotonin or by depletion of the circulating platelets (22). These observations led 
to the suggestion that release  of vasoactive materials from platelets might cause the 
increased vascular permeability and that immune complexes above a certain minimum 
size (19S) would then become trapped along the filtering basement membranes (8, 9). 
In order to examine further this hypothesis, immunological mechanisms of release 
of vasoactive amines from platelets were  sought in vitro which might describe the 
events taking place in vivo leading to deposition of the circulating complexes. To date, 
four immunologic mechanisms have been found which result in release  of histamine 
and serotonin from rabbit platelets (15, 18, 20). Three of these mechanisms apparently 
require activation of the complement sequence by immune complexes,  i.e.,  at least 
through the third component. Immune adherence of the platelets to a complex con- 
sisting of antibody and particulate antigens resulted in release  of vasoactive amines 
by a process  requiring active participation and energy metabolism on the part of the 
platelet. Not all of the complement components were involved, and lysis of the plate- 
lets did not occur. Immune adherence to immune complexes  (in antibody excess) with 
soluble antigens in the presence of serum resulted in lysis of the platelets and release 
of their constituents. This probably resulted from the lytic action of terminal comple- 
* Publication No. 451 fl om the Department of Experimental Pathology, Scripps Clinic and 
Research Foundation, 476 Prospect St., La Jolla, Calif. 92037. The work was supported by 
U. S. Public Health Service Grant AI-07007, National Multiple Sclerosis Society Grant 459, 
and the San Diego County Heart Association. 
:~ Recipient  of  U.  S.  Public  Health  Service Research Career  Development Award No. 
42567-1. 
1 Abbreviations used in this paper: BSA, bovine serum albumin; I*BSA, BSA labeled with 
13II or  1~5I; LDR, leukocyte-dependent reaction; PRP, platelet-rich plasma. 
554 P.  M.  HENSON AND  C.  G.  COCHRANE  555 
ment components (the "innocent  bystander" mechanism). Finally, the presence of low 
numbers of neutrophils during either of these two reactions greatly augmented the 
release of vasoactive amines (19). 
A  fourth  immunological mechanism resulting in  release  of  histamine  and 
serotonin from rabbit platelets involved the reaction of antigen with sensitized 
blood leukocytes,  which  then  subsequently acted  on  the  platelets  to  induce 
release of  their vasoactive amines (17).  The leukocyte responsible has not,  as 
yet,  been unequivocally identified. Since this process did not require comple- 
ment (17),  an attempt could be made to determine whether it or the comple- 
ment-dependent reactions of platelets was involved in the in vivo deposition of 
immune complexes. This has been done by determining whether the deposition 
of immune complexes and the induction  of lesions of immune complex disease oc- 
cur in rabbits depleted of  their complement with  the anticomplementary fac- 
tor from cobra venom (1,  5,  11, 21, 25). Reduction in levels of circulating com- 
plement by administration of additional antigen-antibody  complexes to rabbits 
undergoing immune complex disease was  reported  to prevent the  necrotizing 
arteritis lesions but not to affect the glomerulonephritis (27). The experiments 
described herein attempt to ascertain the role of complement and of the different 
mechanisms of vasoactive amine release from platelets in acute immune complex 
disease. 
Materials and Methods 
Induction of Acute Immune Complex Disease.--New Zealand rabbits weighing 1.5-2.0 kg 
were used. The immune complex disease was induced by a single intravenous injection of 
250 mg/kg of BSA labeled with  131I or  12~I (I*BSA). To enhance the incidence of disease, 
rabbit hyperimmune anti-BSA antiserum, (5 mg of antibody N/kg) was administered 24 hr 
before the antigen injection (22). The course of the disease was followed by frequent deter- 
minations of the I*BSA remaining in a sample of plasma counted in a well-type scintillation 
counter. 
Study of the Circulating Immune  Complexes.~he amounts of immune complexes circu- 
lating in the blood were measured by a determination of the I*BSA precipitated  from the 
plasma by 50% ammonium sulphate and, therefore, bound to globulin (14). The size of the 
circulating complexes was estimated by ultracentrifugation  in 10-37% sucrose gradients as 
described previously (8). Fractions of 15 drops were counted for their content of 131I BSA. 
Sacrifice of Animals  and Examination of Tissues.--Histologic studies of the kidneys and 
coronary arteries were performed following  sacrifice of 16 rabbits at the time when 99% of the 
131I BSA had been eliminated. Frozen sections of the kidneys were examined by fluorescent 
antisera  to BSA, rabbit IgG, and rabbit C3 using the same techniques and reagents as de- 
scribed previously (8). 
Detection of the Leukocyte-Dependent Mechanism of Release of Histamine from Platelets.-- 
Since more than 80% of the histamine in rabbit blood is present in the platelets, release of this 
amine from whole blood cells was taken to represent, at least in greatest part, release from the 
platelets. Blood was obtained at intervals before, during, and after  the occurrence of acute 
immune complex disease and the presence of the leukocyte-dependent reaction, and thus the 
presence of the requisite sensitized cells was determined. The simple procedure for detecting 
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and the formed elements, including platelets, were washed. Antigen (in this case, 60 #g BSA) 
was added to a portion of the washed cells and platelet suspension and was incubated in 2.5 ml 
of Tyrode's sointion  containing0.25% gelatin for 30 rain at 37°C. A control tube contained  cells 
but no antigen. After incubation, the cells were removed by centrifugafion and the supernatant 
fluid  tested for released histamine on the atropinized guinea pig ileum. The percentage of 
histamine released was determined from the total amount liberated by boiling. 
Examination of the Complement-Dependent Mechanisms of Histamine Release  from Platelets.-- 
The details of the preparation of the reagents and performance of the reactions have been 
described previously (18). Platelet-rich plasma (PRP) was prepared by centrifugation (400 g 
for 20  rain)  of blood  taken  from the ear artery directly into ethylenediaminetetraacetate 
(EDTA), a mixture of the disodium and tetrasodinm salts, to yield at pill of 7.2 to a final con- 
centration of 0.005 M. Before the test, 1/~0 volume of a mixture of 2% CaC12 and 2% Mg CI~ 
was added and 10 units/ml heparin was included to prevent clotting. The PRP (0.5 ml) was 
incubated  with or without antigen (0.1 #g 2V-B  SA) or antibody (10 #g 37-IgG rabbit anti-BSA) 
in a total volume of 1 ml for 30 rain at 37°C. The diluent was Tyrode's solution with 0.25% 
gelatin. The platelets were then sedimented and the percentage of histamine released into the 
supernatant fluid was determined. Platelet-rich plasma (0.5 ml)  was also incubated at 37°C 
TABLE  I 
CHso Units in Sera from  Rabbits with Immune  Complex Disease Given Cobra Factor Venom 
Days after 1':ll BSA injection 
2  6  8  9  11 
With cobra factor  61"  52  <6  <6  <6 
Without cobra factor  52*  48  22  25  28 
* Mean of 8 rabbits. 
for 30  min with 3 mg zymosan (Nutritional Biochemical Corp.,  Cleveland, Ohio)  and  the 
release of histamine was again assayed. 
Preparation of Cobra Venom Factor.--The  anticomplementary factor in the venom of the 
cobra Naja naja (Ross Allen Reptile Institute, Silver Springs, Fla.) was prepared according to 
previously described methods (11) by diethylaminoethyl (DEAE) cellulose  chromatography 
and G200 Sephadex (Pharmacia Fine Chemicals Inc., Uppsala, Sweden)  filtration. The ma- 
terial was assayed for anticomplementary activity on normal human serum. One unit of cobra 
venom factor was defined (11) as the quantity of cobra venom factor in 0.1 ml that reduces 
the hemolytic capacity of a  ~0  dilution of normal human serum by 50%. In general, this 
amounted to 4-5 #g of the purified material. 
Injection of Co3ra Venom Factor and Assay of Depletion of Complement.--The  cobra venom 
factor was administered to rabbits essentially according to the regimen  outlined previously 
(11). A total of 800 units of cobra venom factor were injected intraperitoneally into each rabbit 
being divided into two injections per day from the 6th to the llth day after administration of 
antigen. On the 8th day, just before the peak incidence of the disease, the cobra venom factor 
was injected intravenously. Alternatively, cobra venom factor was injected  intravenously 
(200 units/kg) on the 5th, 6th, 7th, and 8th day or on the 6th and 8th  day after antigen in- 
jection. Both regimens were equally effective in reducing complement levels but the intra- 
venous injections resulted in some intravascular hemolysis (1) and so the intraperitoneal route 
was preferred. 
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hemolytic complement (CHs0) by the method of Osier et al.  (26)  and for C3 protein by im- 
munodiffusion against guinea pig anti-rabbit C3. Table I and Fig. 1 show representative assays 
which indicate that the complement levels are reduced to below 15% and the C3 protein has 
almost entirely disappeared during the time when immune complexes are circulating. 
Fla. 1.  Immunodiffusion analysis of C3 depletion of rabbits by cobra venom factor. Center 
well, guinea pig anti-rabbit C3. Wells 1-4, sera from rabbits treated with cobra venom factor. 
Wells 5 and 6, sera from control rabbits. The antiserum recognizes a serum protein in addition 
to C3,  but shows dearly the almost complete loss of  C3  protein in the cobra factor-treated 
sera on both the 8th and llth days after antigen administration. 
TABLE  II 
Protelnuria during Immune Complex Disease in C3-Depleted Rabbits 
Normal C3 levels  C3 depleted 
Number rabbits positive/total  20/21  19/20 
Proteinuria (mean total mg)  945  1145 
Range  (58-2785)  (65-3193) 
RESULTS 
Induction  of Immune Complex Disease in Rabbits Depleted of C3 with Cobra 
Venom Factor: Proteinuria.--In  these  experiments,  immune  complex  disease 
was induced  in  two  groups of rabbits totalling  23  animals each.  C3  levels in 
one group were depleted by the administration of cobra venom factor from the 
6th  day after the  injection  of  antigen.  Animals  in  the  other  group served  as 
controls with normal complement levels. Table II shows the incidence and ex- 
tent of proteinuria in these two groups of rabbits. In each case, animals which 
did not develop an antibody response, i.e.  did not exhibit immune elimination 
of the 1~1I BSA, have been excluded from the results shown. As noted, depletion FIG.  2:  Glomerular lesions in a  rabbit with normal C3 levels.  Endothelial prolifelation is 
marked but there is little neutrophil accumulation. X  450. 
FIG. 3.  Glomerular lesions in a rabbit depleted of C3 with cobra factor. The lesion is identi- 
cal with that in Fig. 2.  X  450. 
558 FIG. 4.  Arterial lesions (coronary artery) in a rabbit depleted of C3 with cobra factor. There 
is lifting of the endothelium and some proliferation and/or round cell accumulation but neutro- 
phils are absent. X  300. 
FIG.  5.  Arterial lesion (coronaly artery)  in a rabbit with normal levels of C3. Endothelial 
proliferation, neutrophil accumulation, and breaks in the internal elastic lamina are apparent. 
X  300. 
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of C3 had no effect on the development of proteinuria in acute immune complex 
disease. 
Histology and Immune Complex Deposition.--Rabbits  in one experiment were 
sacrificed at the time when 99 % of the antigen had been eliminated and tissues 
were  taken  for  immunofluorescent  and  histologic  examination.  The  typical 
granular pattern of IgG localized in the glomeruli was observed in rabbits from 
both groups. However, C3 could only be found in the kidneys of those animals 
with  normal  complement levels.  In vivo depletion  of  C3  with  cobra venom 
factor had  thus  prevented  the  fixation  of  C3  to  the  immune  complexes  de- 
positing in the kidneys. 
Histologically,  glomeruli  from rabbits  with  normal  or  depleted  C3  levels 
appeared  identical  (Figs.  2  and  3),  showing  typical  proliferative glomerulo- 
nephritis. The incidence of these glomerular lesions is shown in Table III and 
TABLE  III 
Incidence  of Lesions  of Immune Complex Disease in C3-Depleted Rabbits 
Number of animals showing lesions 
Normal C3 levels  C3 depleted 
Glomerularlesions  16/17  13/13 
Cardiovascular lesions 
Intlmal changes  5/5  6/6 
Neutrophilinfiltration and necrosis  5/5  0/6 
was similar in both groups. Neutrophil accumulation was not seen in glomeruli 
of either group of animals. 
In contrast to the lack of effect on the glomerulonephritis,  depletion  of C3 
did change the quality of the arterial lesions. Figs. 4 and 5 show sections of the 
coronary  artery from a  rabbit  treated  with  cobra venom factor and  from a 
control  animal with  normal complement levels. The characteristic neutrophil 
infiltration,  the subsequent damage to the internal elastic lamina, and necrosis 
of media and adventitia were absent in the cobra factor-treated rabbits. How- 
ever, of interest was the elevation of intima away from the underlying internal 
elastic lamina with slight endothelial proliferation and/or round cell accumu- 
lation in the coronary arteries in these latter animals. This is illustrated in Fig. 
4. The incidence of these lesions and the site (around the heart valves, aorta, 
and  at  the  coronary outflow)  were  the  same  as  the  more complete,  necrotic 
lesions in normal rabbits (Table III). 
The Effect of Cobra Factor on the Presence of Circulating Immune Complexes.- 
In order to determine whether treatment with cobra venom factor was affecting 
the immune response of the rabbits or the quality of the immune complexes, 
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for two representative rabbits  (one depleted  of  C3  and  one with  normal  C3 
levels) in Fig. 6. It was found that the pattern of antigen clearance was identical 
in the two groups of animals. Although individual variation in rates of antigen 
elimination did occur,  rabbits from either group exhibited the same variation 
and individuals could be paired as shown in Fig. 6. The percentage of 125I BSA 
which was bound to globulin (as determined by ammonium sulphate precipita- 
tion  of the plasma)  again showed individual variation but was similar in the 
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Fro. 6. The course of acute immune complex disease in two representative rabbits.  (e) 
Rabbit treated with cobra factor during the period indicated by the solid bar.  (O) Control 
rabbit with normal C3 levels, lSlI BSA in the immune complexes (I.C.) was measured after 
ammonium sulphate precipitation of the serum. 
two groups. This indicated  the presence of comparable amounts of circulating 
immune complexes. Fig.  6  also demonstrates that the presence of proteinuria 
in these two rabbits occurred over the same time period and to approximately 
the same degree. 
At  the  time  when  the  largest  amount  of  circulating  immune complexes 
could be detected,  plasma was taken from the rabbits in each group and im- 
mediately sedimented in sucrose-density gradients to determine the size of the 
immune  complexes.  Again,  no  difference  could  be  detected  between  those 
rabbits receiving cobra venom factor  and  those  which  did  not,  although  in- 
dividual  variation  was  noted.  Rabbits  producing  proteinuria  had  complexes 
extending up to and beyond 19S in size, as described previously (8). 562  ACUTE  IMMUNE  COMPLEX  DISEASE  IN  RABBITS 
t£ffect  of Cobra Faclor on the Release of Histamine from Plalelets.--Since the 
release of vasoactive amines from platelets has been implicated in the deposi- 
tion  of immune  complexes  (23),  the  ability of immunological reactions to  in- 
duce  this release of amines from  the blood of the  C3-depleted rabbits under- 
going  immune  complex  disease  was  examined.  Table  IV  depicts  the  results. 
Three  reactions  were  performed.  (a) A  test  for  the  presence  of  complement- 
dependent (nonlytic) release of histamine from platelets (18). Zymosan particles 
were added to platelet-rich plasma of rabbits with normal or depleted C3 levels. 
The zymosan fixes complement through C3 and induces adherence of the plate- 
TABLE IV 
The Effect of Treatment with Cobra Factor on the Average Percentage of Itistamine  Released 
In Vitro by Platelets  from Rabbits with Immune Complex Disease 
C3 depleted  Normal C3 levels 
Time of testing  (6 rabbits)  (6 rabbits 
(%)  (%) 
At the time of Ag elimination 
PRP +  zymosan  10  52 
PRP q- Ag  3  8 
PRP -k Ag -k Ab  1  30* 
Washed blood cells  9  6 
Washed blood cells +  Ag  8  4 
2-3 days after Ag elimination 
Washed blood cells  17  15 
Washed blood Cells -k Ag  75  63 
Zymosan  =  3 #g; Ag  =  0.1 #gN BSA; Ab  =  10 #g z¢ rabbit IgG antiBSA; PRP  = 
platelet-rich plasma (see Materials and Methods section).  Washed  blood  cells  include  the 
platelets. The figures represent mean percentages  of histamine released. 
* Addition of cobra factor in vitro to these PRP reduced the released  histamine due to 
Ag +  Ab from 30 to 4%. 
lets and release of their vasoactive amines. As shown  in Table IV, the release 
of histamine, which was  observed in PRP  from animals with normal C3,  was 
inhibited  in  PRP  from  C3-depleted  rabbits,  confirming  the  complement- 
dependence  of  this  reaction.  (b)A  test  for  the  presence  of  complement-de- 
pendent  (lyric)  release  of  histamine  from  platelets  (18).  Antigen-antibody 
complexes  formed  in  antibody  excess  with  protein  antigens  also  induce  re- 
lease  of  histamine  from  platelets  by  a  complement-dependent  mechanism. 
The  ineffectiveness of this process in PRP  from  C3-depleted  animals is again 
shown  in Table IV.  In addition,  the release which  did occur with PRP  from 
rabbits  with  normal  complement  levels  was  inhibited  if  cobra  factor  was 
added in vitro. Antigen alone incubated with PRP at the time of antigen elimi- 
nation  did  not  induce  histamine  release.  However,  if  incubated  with  PRP P.  IVf. HENSON  AND  C.  G.  COCIIIL~NE  563 
taken 2 days after elimination (not shown), i.e. when free antibody was circu- 
lating,  20%  histamine  was  released  in  the  case  of  animals  with  normal  C3 
levels. (c) A  test for the presence of the leukocyte-dependent release of hista- 
mine  from platelets  (17).  The complement-independent release  of histamine 
from platelets requires blood leukocytes but not plasma. Accordingly, rabbits 
from both  groups  were  examined  at  the  time  of  antigen  elimination  by in- 
cubating washed blood cells (including platelets)  with  antigen.  At  this  time, 
blood from neither group exhibited release of histamine (Table IV). However, 
this  reaction has  previously been reported  (17)  to  appear  after  the  antigen 
has  been  eliminated,  not  while  it  is  still  circulating  in  the  blood.  For  this 
reason, some rabbits in each group were not sacrificed at the time of antigen 
elimination but were allowed to proceed for 2-3  days while  their blood was 
being examined for the presence of this leukocyte-dependent release of hista- 
mine from platelets. 
Table IV shows  that  2  days after the  immune  elimination of antigen,  the 
leukocyte-dependent reaction  (LDR)  appeared  in  the  blood  of rabbits  from 
either group.  Fig.  6  includes measurements  of this  reaction in  a  rabbit with 
normal C3 level or a rabbit depleted of C3 during the complete course of the 
immune complex disease. The results of each examination of the washed blood 
cells  are expressed as the percentage of histamine released by 62/zg of BSA. 
It should be noted that the test is only roughly quantitative since the platelets 
within the blood sample are being used as a source of the release of histamine 
and these may vary in number. Nevertheless, it does give a guide to the strength 
of  the  reaction,  i.e.,  the  number  of reactive leukocytes  (17).  In  every case, 
tubes without antigen were included as controls. It was found that  identical 
responses occurred, whether or not the rabbits were depleted of C3. This was 
equally true in the first few days after antigen elimination, when the LDR was 
becoming detectable and while the C3 levels were still depressed. 
Correlation of Leukocyte-Dependent Release of Vasoactive Amines from Platelets 
and the Deposition of Immune Complexes in  Vessels and Glomerular Injury.- 
The ability of rabbits to succumb to the glomerulonephritis of immune complex 
disease,  even  though  the  C3  had  been  depleted with  cobra factor,  suggests 
that  the mechanism  of release of histamine from platelets which did not re- 
quire complement might be involved in the deposition of the complexes. Un- 
fortunately, the presence of the reaction in  the blood cannot be detected in 
the presence of circulating antigen. However, since the LDR can be observed 
after antigen elimination, immune complex disease was induced in 30 rabbits 
whose blood was examined during and after the clearance of radiolabeled BSA. 
The presence of the disease was determined by daily examination of the urine 
for  protein.  17  out  of  30  rabbits  produced  antibody,  formed  complexes  in 
the  circulation,  and  developed proteinuria;  8  others with  complexes did not 
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immune elimination  or  the presence of complexes. The poorer responsiveness 
of  these  rabbits permitted  an interesting  correlation between  the presence of 
proteinuria  and  the  LDR.  Of  the  17  rabbits  with  proteinuria,  i.e.  having 
immune complex deposition in the glomeruli and glomerulitis,  16 developed a 
detectable LDR within 2 days after antigen elimination (Table V). Of the 8 rab- 
bits which formed complexes in the circulation and eliminated the antigen but 
did not develop proteinuria, 7 did not exhibit an LDR in the blood at any time. 
The 8th  animal was of particular interest since it eliminated the antigen,  ex- 
hibited  an  LDR,  but  did  not  develop proteinuria.  Examination  of  the  sedi- 
mentation  characteristics  of the  circulating  immune complexes in  this  rabbit 
(see  below)  revealed  that  they were  less  than  19S  in  size,  i.e.,  too  small  to 
become deposited in glomeruli and induce nephritis  (8). 
Size of Immune  Complexes,  the  LDR,  and  Glomerulonephritis.--Plasma  was 
taken from many of the rabbits in the experiment described above for sucrose 
density  gradient  analysis  of  their  circulating  immune  complexes.  Control 
TABLE V 
Corrdation of Leukocyte-Dependent Rdease from Platelets and Glomerular Injury 
Number of animals with leukocyte- 
dependent  release of histamine 
Rabbits with proteinuria  16/17 
Rabbits without proteinuria  1"/8 
* This rabbit had light complexes, see Fig. 3. 
samples  analyzed  2  days  after  antigen  administration  revealed  only  a  ho- 
mogenous 4.5S  peak of radiolabeled  BSA.  Plasmas  were  then  examined  at  a 
time  when  at  least  25 %  of  the  circulating  antigen  was  bound  to  globulin 
(determined  by  precipitation  with  50%  saturated  ammonium  sulphate). 
The samples were immediately placed on  a  10-37 %  sucrose density gradient 
and  centrifuged  at  50,000  rpm for 5  hr.  15  drop samples were removed and 
counted for 125I BSA. IgM, IgG, and albumin were used as 19S,  7S,  and 4.5S 
markers, respectively. Figure 7 shows plasma from three representative animals 
analyzed in this way. 
In the plasma from rabbit 90, antigen was found extending into the gradient, 
i.e.  complexed to globulin,  as far as the 19S marker. The animal developed an 
LDR after antigen  elimination  and  exhibited proteinuria.  In contrast,  rabbit 
88  did  not  develop  an LDR  and  did  not  excrete  protein  in  the  urine  even 
though  the  circulating  immune  complexes were  as  large  in  size  as  those  of 
rabbit  90.  Rabbit 93  is  the  one  referred  to  above whose immune  complexes 
were small, only extending slightly beyond the 7S marker. In this case, despite 
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DISCUSSION 
Three major observations have arisen from the experiments described herein. 
(a) Complement  components  beyond  C2  did  not  appear  to  be  involved  in 
the deposition of immune complexes, either in the arteries or in the glomerulus 
of rabbits with acute immune complex disease. (b) A strong correlation existed 
between  the  presence  of  a  mechanism  of  release  of  vasoactive  constituents 
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FIG. 7.  Sucrose  density ultracentrifugation of sera from three representative rabbits during 
the course of immune complex disease. The direction of centrifugation is to the left. Only the 
animal which had large circulating complexes  and also exhibited an LDR reaction developed 
proteinuria. 
from platelets  that  requires  leukocytes  and  the  deposition  of  immune  com- 
plexes  in  blood  vessels  with  the  subsequent  development  of  injury  to  the 
glomeruli.  Complement  did  not  appear  to  be  required  for  this  process.  (c) 
The glomerular injury which  accompanies the deposition of complexes in the 
kidney still occurred in the absence of C3. In complete contrast, however, the 
necrotizing arteritis lesions which follow the deposition of immune complexes 
in  the  arteries  did require  the  action  of complement components beyond  C2 
in addition to the presence of circulating neutrophils (22). 
Plasma  Complement and the Deposition of Immune Complexes.--The  results 566  ACUTE  IMMUNE  COMPLEX  DISEASE  IN  RABBITS 
indicated  that  deposition  of  complexes  in  the  glomeruli was  completely un- 
affected by depletion of C3 with cobra factor since the extent and the severity 
of glomerulonephritis  was  unaltered  (Table  II).  In  addition,  the  complexes 
could  be  detected  in  the  glomeruli  by  immunofluorescence,  although  as  ex- 
pected and in confirmation of the effectiveness of the cobra factor treatment, 
C3 was not seen with the immune complexes in these rabbits. 
Evidence  of  deposition  of  immune  complexes in  the  arteries  was  also  ob- 
tained in that distinct changes in the intima were observed in the C3-depleted 
rabbits. These lesions consisted of raising of the intimal layer, endothelial cell 
proliferation,  and/or  mononuclear  cell infiltration.  These  changes  have  been 
described  as  the  earliest  manifestations  of  the  arteritis  of  immune  complex 
disease  occurring  before  accumulation  of  neutrophils  (23),  and  were  felt  to 
indicate  the  immune complexes had  accumulated  at  these  sites.  In  addition, 
the incidence of these alterations in the rabbits treated with cobra factor was 
the same as that of the more severe necrotic lesions in the animals with normal 
levels of complement (see discussion below). 
Depletion of C3  (and later components)  also prevented release of histamine 
from platelets by the  complement-dependent reactions.  Neither  a  particulate 
antigen  (zymosan)  nor  antigen-antibody  complexes  formed  with  BSA  as 
antigen were capable of inducing release of histamine from platelets  in plate- 
let-rich  plasma from the  rabbits  treated  with  cobra venom factor.  This  was 
contrasted  with  the  release  observed  in  the  case  of  the  control  animals  not 
receiving  the  anticomplementary material.  The  results  suggested  that  these 
complement-dependent  mechanisms  of  release  of  platelet  constituents  were 
not of prime importance in the generation  of increased vascular permeability 
and deposition of complexes in acute immune complex disease. 
Correlation  of  the  Leukocyte-Dependent  Mechanism  of  Histamine  Release 
from  Platelets with  the  Deposition  of  Immune  Complexes.--The  leukocyte- 
dependent  mechanism  of  immunological  release  of  histamine  from platelets, 
however,  did  not  require  plasma  as  a  source  of  complement  (17)  and  was 
observed in rabbits depleted  of C3  with  cobra venom factor. When  attempts 
were made to determine the incidence  of the LDR mechanism in rabbits de- 
veloping glomerulonephritis, a striking correlation was observed. Of 17 rabbits 
with circulating complexes and evidence of glomerular injury,  16 possessed the 
LDR  mechanism.  By  contrast,  of  8  rabbits  with  circulating  complexes  but 
without  glomerulonephritis,  7 did  not  exhibit  the LDR mechanism. The sole 
exception in  this  latter  correlation  was found  to  have  immune complexes in 
the circulation that were too small, i.e.  less than 19S in size, so that deposition 
could  not be expected in  any event.  Since the  blood was  examined for LDR 
after the elimination of antigen, the rabbits could not be sacrificed at the time 
of maximum severity of arteritis.  Accordingly,  no direct correlation with  this 
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The leukocyte-dependent reaction has been described in a number of labora- 
tories  (2,  17,  28,  29,  31)  and  involves the reaction of specific antigen  with  a 
circulating sensitized leukocyte. This interaction subsequently causes platelets 
to release their content of vasoactive amines. The nature of the leukocyte has 
not yet been unequivocally determined. There is some evidence that a soluble 
factor  is  released  from these  cells  after  reaction  with  antigen  and  that  this 
then acts On the platelets to induce release of at least some of their histamine 
and  serotonin  (17).  Recently,  experiments  in  this  laboratory  and  in  others 
(13)  have shown that the LDR can be transferred to normal recipient rabbits 
with  serum from immunized  animals. Washed  leukocytes from the recipients 
then react with  antigen,  and in the presence of platelets  release of histamine 
ensues. These experiments have raised the possibility that a form of cytophilic 
(4)  or cytotropic antibody is responsible for the LDR. An LDR was not de- 
tected during  the time that antigen was still circulating.  In possible explana- 
tion  of  this,  when  leukocytes  were  subjected  to  incubation  with  antigen  in 
vitro in previous studies (17), they were no longer capable of causing release of 
histamine  from platelets.  This  desensitization  may account  for  the  inability 
to detect  the reaction  in  the blood before antigen  elimination.  Alternatively, 
when sensitized  leukocytes react with  antigen  in vivo, they may be removed 
fronl the circulation,  obviating detection. On the other hand,  after the antigen 
has  gone,  the LDR could be detected,  increasing  in  strength for a  few days, 
and  then  waning  slowly.  The  presence  of sensitized  leukocytes  in  the  blood 
indicated  by  this  reaction,  therefore,  follows  a  similar  time  course  to  the 
presence of circulating antibody. 
The  Mediation  of  Glomerular and  Arterial  Injury.--Consequent  to  the 
deposition  of  immune  complexes,  injury  to  the  tissues  occurs.  The  studies 
reported herein indicate that injury to the glomerulus does not follow the same 
mediation pathway as damage to the arteries. 
Arteritis.--Depletion  of  C3  (and  C5  and  C6)  had  a  marked  effect on  the 
arteritis  in  this  disease  since  it  prevented  the  characteristic  neutrophil 
accumulation.  There  are  two  likely  ways  in  which  fixation  of  complement 
might  contribute  to  the  accumulation  of  neutrophils.  The  chemotactic  ac- 
tivity for neutrophils  of a  number of complement components  (or fragments 
thereof)  are  well-known  (3,  30,  32-35).  However,  it  is  difficult  to  imagine 
how  chemotactic  factors  released  from  complexes  deposited  in  the  walls  of 
large arteries with high flow rates could set up suitable concentration gradients 
for this process to be important in neutrophil  accumulation.  Instead the proc- 
ess  of immune  adherence  seems  a  more likely possibility  to  account  for  the 
complement  requirement.  Neutrophils  show  strong  adherence  reactions  to 
complexes which have bound  C3  (16,  24),  (and to a  lesser extent to the fixed 
immunoglobulin itself)  and might thus remain adherent to antigen-antibody- 
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the arteries. This may be augmented by the occurrence of the lesions at sites 
of more turbulent flow where greater contact between neutrophils and bound 
C3 would occur. 
The importance of neutrophils in  the production of injury to blood vessel 
walls  in  acute  immune  complex disease  has  been  previously reported  (22). 
Depletion  of  the  neutrophils  by  anti-neutrophil  antibody  was  effective  in 
preventing the  necrotizing arteritis while not  affecting the  deposition  of the 
immune  complexes. Adherence of neutrophils  to immune  complexes and  the 
subsequent  phagocytosis of  them  are  both  stimuli  which  lead  to  release  of 
enzymes and  tissue-damaging  agents  from the  cells  (Henson,  P.  M.,  manu- 
script in preparation).  It is  therefore suggested  that  the pathogenesis of the 
arteritis  comprises  (a) increased  vascular  permeability  following  platelet 
impingement on vessel walls  and release of vasoactive amines by the  leuko- 
cyte-dependent process; (b) deposition of immune complexes greater than 19S 
in  size  at  these  sites;  (c) fixation  of  complement  by  the  complexes  (which 
probably occurs  while  they  are  still  circulating);  (d)complement-dependent 
accumulation of neutrophils;  (e) adherence to,  and phagocytosis of,  the com- 
plexes  by neutrophils;  (f) release of neutrophil  constituents;  (g) digestion  of 
materials in the vessel walls and penetration of neutrophils, resulting in nledial 
and adventitial necrosis. 
Glomerulitis.--In  contrast to its effect on the arteritis,  depletion of the  C3 
did not  alter in  any measurable way the incidence, character,  or severity of 
the glomerulonephritis. It had previously been shown that  depletion of neu- 
trophils had  little effect on  the kidney lesion in  this  acute immune  complex 
disease (22). Indeed, few neutrophils are seen in acute immune complex nephri- 
tis  of rabbits.  This  should  be contrasted with  the  importance  of these  cells 
and complement in nephrotoxic nephritis produced by antibodies to glomerular 
basement  membrane  (12).  It  appears,  therefore,  that  deposition  of immune 
complexes along the filtering basement membrane in the glomerulus results in 
damage  (exemplified  by  proteinuria  and  proliferative  glolnerulonephritis) 
by an  as  yet undefined process. It may be that mere deposition of material 
along the membrane itself alters its permeability properties. 
Effects  of Cobra  Venom Factor.--In  the course of these studies,  conclusions 
have been drawn from the effect of cobra venom factor in depleting C3  and 
later complement components from the blood of rabbits.  Consideration must 
be  given to  the possibility  that  cobra venom factor is  interfering  with  the 
disease process in a manner unrelated to its direct effect (in combination with 
the  proinactivator in  plasma)  on  C3,  and  thus  on  the  later  components  of 
complement.  However,  in  a  study  of  many  physiological parameters  (11), 
little or no effect of cobra venom factor was found on numbers or performance 
of neutrophils  and platelets  or on the kinin or coagulation systems. 
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the generation of anaphylatoxins, which in their turn induce release of hista- 
mine from mast  cells  (10).  This raises  the possibility that  the  cobra venom 
factor itself, by acting  on the  C3  which  is  synthesized during  the  course of 
the depletion process,  can cause an increase in vascular permeability by lib- 
erating anaphylatoxins and thus permit complex deposition. However, it has 
been clearly demonstrated that platelets  are required for the deposition (23) 
and  anaphylatoxins  do  not  affect this  reservoir of  vasoactive  amines  (20). 
Moreover, the quantities of C3  produced are not very great and the rate of 
anaphylatoxin  inactivation  in  rabbit  plasma  is  extremely rapid.  It  is  felt, 
therefore, that a role for cobra factor in initiating the disease is unlikely and 
that the deposition of the immune complexes is independent of the later com- 
plement components. 
SUMMARY 
By  depletion  of  C3  from  rabbits  undergoing  acute  experimental  immune 
complex disease with an anticomplementary factor in cobra venom, it has been 
possible  to  demonstrate  that  deposition  of  the  complexes  in  arteries  and 
glomeruli does not require the complement components reacting after C2. 
Immunological reactions, in which platelets release their vasoactive amines, 
have been  examined in  rabbits  undergoing immune  complex disease.  A  cor- 
relation  was  obtained  between  the  presence  of  a  complement-independent 
reaction which required blood leukocytes, antigen and platelets, the deposition 
of immune complexes, and the induction of glomerulonephritis. 
C3 depletion did, however, have a marked alleviating effect on the severity 
of the arterial lesions. Neutrophil accumulation and the subsequent necrotizing 
arteritis were prevented. In contrast,  the  character  and  severity of  the  glo- 
merulonephritis was not altered by depletion of later-acting complement com- 
ponents. 
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